Home » ZERIA PHARMACEUTICAL LICENSES GASTRIC ULCER DRUG TO SK CHEMICALS
ZERIA PHARMACEUTICAL LICENSES GASTRIC ULCER DRUG TO SK CHEMICALS
Zeria Pharmaceutical announced on March 2 that it had concluded a licensing agreement with Korean company SK Chemicals as of February 27. Under the terms of the agreement, SK Chemicals is licensed to develop and sell Promac Granules 15%, ZERIA's proprietary ethical agent for the treatment of gastric ulcers, exclusively in Korea.
JCN Network (http://japancorp.net/Article.Asp?Art_ID=12016)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May